S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

VRPX Virpax Pharmaceuticals Inc

0.341

-0.008 (-2.29%)

Last Updated: 08:37:46

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Virpax Pharmaceuticals (NASDAQ:VRPX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Virpax Pharmaceuticals Charts.

Virpax Pharmaceuticals (NASDAQ:VRPX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Virpax Pharmaceuticals Charts.

Virpax Pharmaceuticals Inc News

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 8 January 2025 (7 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 7 January 2025 (1 week ago) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Monday 30 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 30 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 18 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 13 December 2024 (1 month ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Monday 9 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 29 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 26 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™
Friday 22 November 2024 (2 months ago) • Business Wire

Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative
Thursday 21 November 2024 (2 months ago) • Business Wire

More Virpax Pharmaceuticals Inc News Articles

Vision Airships (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions